Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

NCT07039474 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07039474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07039474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Recruiting
Start date
September 8, 2026
Completion date
December 15, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, esophagus cancer, hematologic cancer, kidney cancer, lung cancer, lymphoma, solid tumor malignancies, stomach cancer